Detalhe da pesquisa
1.
Pharmacokinetics of gefitinib in elderly patients with EGFR-mutated advanced non-small cell lung cancer: a prospective study.
BMC Pulm Med
; 22(1): 454, 2022 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36451169
2.
Alteration in the Plasma Concentrations of Endogenous Organic Anion-Transporting Polypeptide 1B Biomarkers in Patients with Non-Small Cell Lung Cancer Treated with Paclitaxel.
Drug Metab Dispos
; 48(5): 387-394, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32114508
3.
High-throughput method to analyze tegafur and 5-fluorouracil in human tears and plasma using hydrophilic interaction liquid chromatography/tandem mass spectrometry.
Rapid Commun Mass Spectrom
; 33(24): 1906-1914, 2019 Dec 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-31323696
4.
Coadministration of cytotoxic chemotherapeutic agents with irinotecan is a risk factor for irinotecan-induced cholinergic syndrome in Japanese patients with cancer.
Int J Clin Oncol
; 24(2): 222-230, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-30244364
5.
Lack of correlation between the costs of anticancer drugs and clinical benefits in Japan.
Cancer Sci
; 109(12): 3896-3901, 2018 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-30315613
6.
Organic Cation Transporter 1 Is Responsible for Hepatocellular Uptake of the Tyrosine Kinase Inhibitor Pazopanib.
Drug Metab Dispos
; 46(1): 33-40, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29089306
7.
Phase I/II study of docetaxel combined with resminostat, an oral hydroxamic acid HDAC inhibitor, for advanced non-small cell lung cancer in patients previously treated with platinum-based chemotherapy.
Invest New Drugs
; 35(2): 217-226, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28138828
8.
Incidence of Ophthalmic Disorders in Patients Treated with the Antineoplastic Agent S-1.
Gan To Kagaku Ryoho
; 44(6): 501-506, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28698442
9.
Optimal dose of gemcitabine for the treatment of biliary tract or pancreatic cancer in patients with liver dysfunction.
Cancer Sci
; 107(2): 168-72, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26595259
10.
Patritumab plus trastuzumab and paclitaxel in human epidermal growth factor receptor 2-overexpressing metastatic breast cancer.
Cancer Sci
; 107(10): 1465-1470, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27452985
11.
Increased Plasma Concentrations of Unbound SN-38, the Active Metabolite of Irinotecan, in Cancer Patients with Severe Renal Failure.
Pharm Res
; 33(2): 269-82, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26337772
12.
Safety and pharmacokinetics of ramucirumab in combination with docetaxel in Japanese patients with locally advanced or metastatic breast cancer: a Phase Ib study.
Jpn J Clin Oncol
; 46(12): 1088-1094, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27608646
13.
Phase 1 combination study of eribulin mesylate with trastuzumab for advanced or recurrent human epidermal growth factor receptor 2 positive breast cancer.
Invest New Drugs
; 33(1): 119-27, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25242374
14.
A phase I study of farletuzumab, a humanized anti-folate receptor α monoclonal antibody, in patients with solid tumors.
Invest New Drugs
; 33(2): 332-40, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25380636
15.
Randomized phase II trial of nimotuzumab plus irinotecan versus irinotecan alone as second-line therapy for patients with advanced gastric cancer.
Gastric Cancer
; 18(4): 824-32, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25185971
16.
The SOFT trial: a Phase III study of the dihydropyrimidine dehydrogenase inhibitory fluoropyrimidine S-1 and oxaliplatin (SOX) plus bevacizumab as first-line chemotherapy for metastatic colorectal cancer.
Future Oncol
; 11(10): 1471-8, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25963425
17.
Safety, pharmacokinetics and efficacy findings in an open-label, single-arm study of weekly paclitaxel plus lapatinib as first-line therapy for Japanese women with HER2-positive metastatic breast cancer.
Int J Clin Oncol
; 20(6): 1102-9, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25967286
18.
Phase II trial of nanoparticle albumin-bound paclitaxel as second-line chemotherapy for unresectable or recurrent gastric cancer.
Cancer Sci
; 105(7): 812-7, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24716542
19.
Regorafenib in Japanese patients with solid tumors: phase I study of safety, efficacy, and pharmacokinetics.
Invest New Drugs
; 32(1): 104-12, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23553067
20.
Direct inhibition and down-regulation by uremic plasma components of hepatic uptake transporter for SN-38, an active metabolite of irinotecan, in humans.
Pharm Res
; 31(1): 204-15, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23921491